- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł553.4m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł30.45
7D
-2.6%
1Y
6.8%
Ryvu Therapeutics
Market Cap: zł342.2m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł14.84
7D
-3.0%
1Y
-52.3%
Molecure
Market Cap: zł117.4m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.67
7D
-2.6%
1Y
1.3%
Poltreg
Market Cap: zł106.5m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł18.80
7D
0.3%
1Y
-41.3%